Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Do not look at us one quarter from the next because the order book is such that the revenues might be lumpy and if you look at our fiscal performance, EBITDA margins have been around 40% plus and PAT margins have been 30% plus. I would say strong financial performance but yes, not something to look at quarter-on-quarter but year-to-date year on year.”
Mappls: "Do not look at us one quarter from the next because the order book is such that the revenues might be lumpy and if you look at our fiscal performance, EBITDA margins have been around 40% plus and PAT margins have been 30% plus. I would say strong financial performance but yes, not something to look at quarter-on-quarter but year-to-date year on year."